Teiko Bio — 1 certified H-1B filings (FY2022)

1
Filings · FY2022
$135k
Median base · FY2022
Senior Scientist, Medical Strategy
Top role · 1 all-time
TX
Top state · 1 all-time
FY

Teiko Bio filed 1 certified H-1B LCAs in FY2022, with a median base salary of $135k and the middle 50% of offers between $135k and $135k. Across all years it has 1 certified filings since FY2022, most often for Senior Scientist, Medical Strategy in Texas.

How much does Teiko Bio pay H-1B workers?

Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $135k median in FY2022. Base pay only — hover a year for its figures.

$120k$130k$140k$150k’22

How has Teiko Bio's H-1B hiring changed by year?

1 certified filings on record (FY2022).

Teiko Bio certified H-1B filings and base salary by fiscal year
Fiscal yearFilingsvs prior FYMedian base
FY20221—$135k

Which wage levels does Teiko Bio file?

DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 0% of Teiko Bio's filings sit at Level III–IV. A heavy I–II skew reads as entry-level or contractor-style hiring; a heavy IV skew as senior in-house roles — and higher levels earn more lottery entries.

Share of 1 filings with a wage level · all years

100%
  • Level II100.0%1

What jobs does Teiko Bio sponsor for H-1B?

The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.

Teiko Bio most-sponsored H-1B job titles with base-salary percentiles
Job titleFilingsMedian base
Senior Scientist, Medical Strategy1$135k

Where does Teiko Bio hire H-1B workers?

Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.

11Certified filings (log scale)
Teiko Bio H-1B worksite states
StateFilingsMedian base
TX1$135k

What has Teiko Bio filed recently?

Every certified LCA on record for Teiko Bio: job title, worksite, prevailing-wage level and the offered base salary.

Teiko Bio recent certified H-1B LCA filings
FYJob titleBase salary
2022Senior Scientist, Medical Strategy$135,000

Common questions about Teiko Bio's H-1B filings

How much does Teiko Bio pay H-1B workers?
Teiko Bio's median certified H-1B base salary is $135k (FY2022), from 1 filings. See the full salary distribution and percentiles above.
How many H-1B workers does Teiko Bio sponsor?
Teiko Bio has 1 certified H-1B Labor Condition Applications on record (FY2022).
What jobs does Teiko Bio sponsor for H-1B?
Teiko Bio's most-sponsored H-1B roles include Senior Scientist, Medical Strategy.
Where does Teiko Bio hire H-1B workers?
Teiko Bio's top H-1B worksite states are TX.
Does a certified LCA mean an H-1B visa was approved?
No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
What salary do these figures show?
The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
What do prevailing-wage levels I–IV mean?
The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.

Keep exploring

Browse all sponsors →

Calculate your H-1B lottery odds →orCheck out the insights →

Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2022). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →